Adult-Onset Hypogonadism (Q26747149)

title

Adult-Onset Hypogonadism (English)

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Allen D Seftel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Hossein Sadeghi-Nejad

object named as

Hossein Sadeghi-Nejad

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Wayne J G Hellstrom

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Irwin Goldstein

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Lawrence S Hakim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Ira D Sharlip

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Arthur L Burnett

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Mohit Khera

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Culley C Carson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Adrian S Dobs

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Martha M Faraday

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Ravi Kacker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Tobias S Köhler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jesse N Mills

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Martin Miner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Stephen J Winters

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

English

0 references

publication date

July 2016

0 references

published in

Mayo Clin Proc

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

908-926

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

Low serum testosterone and mortality in male veterans

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Comparative Safety of Testosterone Dosage Forms

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Testosterone levels in obese male patients with obstructive sleep apnea syndrome: relation to oxygen desaturation, body weight, fat distribution and the metabolic parameters

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Testosterone Replacement Therapy on the Natural History of Prostate Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Subnormal serum testosterone levels in male internal medicine residents

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Contraceptive efficacy of testosterone-induced azoospermia in normal men

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Free testosterone: clinical utility and important analytical aspects of measurement

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Endocrinology of the aging male

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

A new era of testosterone and prostate cancer: from physiology to clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Anabolic steroid-induced hypogonadism: diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Current Practices of Measuring and Reference Range Reporting of Free and Total Testosterone in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Obesity and late-onset hypogonadism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Hypogonadism, erectile dysfunction and endothelial dysfunction among HIV-infected men

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Interlaboratory comparison study of serum total testosterone [corrected] measurements performed by mass spectrometry methods.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Sex hormone-binding globulin and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Effects of 5-year treatment with testosterone undecanoate on lower urinary tract symptoms in obese men with hypogonadism and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Serum LH concentrations in hypogonadal men during transdermal testosterone replacement through scrotal skin: further evidence that ageing enhances testosterone negative feedback

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Androgen administration in middle-aged and ageing men: effects of oral testosterone undecanoate on dihydrotestosterone, oestradiol and prostate volume

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Identification of late-onset hypogonadism in middle-aged and elderly men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Gonadal steroids and body composition, strength, and sexual function in men

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Effects of Testosterone Treatment in Older Men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Risks of testosterone-replacement therapy and recommendations for monitoring

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Diagnosing and treating testosterone deficiency in different parts of the world. Results from global market research

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Erectile dysfunction and hypogonadism among men with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

The impact of body mass index on semen parameters and reproductive hormones in human males: a systematic review with meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Spermatogenesis after cancer treatment: damage and recovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Hormones and prostate cancer: what's next?

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Testosterone, thrombophilia, thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Metabolic sequelae associated with androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Androgens and obesity

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Evolving utility of sex hormone-binding globulin measurements in clinical medicine

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Testosterone replacement therapy and polycythemia in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

The risk of adverse outcomes in association with use of testosterone products: a cohort study using the UK-based general practice research database

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Sex-hormone-binding globulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Reversal of polycythaemia induced by intramuscular androgen replacement using transdermal testosterone therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Healthier lifestyle predicts higher circulating testosterone in older men: the Health In Men Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

The NERI Hypogonadism Screener: psychometric validation in male patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Adverse effects of psychosocial stress on gonadal function and insulin levels in middle-aged males

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Prevalence of hypogonadism in males aged at least 45 years: the HIM study

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

A practical guide to male hypogonadism in the primary care setting

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Androgen causes growth suppression and reversion of androgen-independent prostate cancer xenografts to an androgen-stimulated phenotype in athymic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

The effect of statins on testosterone in men and women, a systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Graded inhibition of pulsatile luteinizing hormone secretion by a selective gonadotropin-releasing hormone (GnRH)-receptor antagonist in healthy men: evidence that age attenuates hypothalamic GnRH outflow

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Testosterone Gel Combined with Depomedroxyprogesterone Acetate Is an Effective Male Hormonal Contraceptive Regimen and Is Not Enhanced by the Addition of a GnRH Antagonist

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Prevalence of symptomatic androgen deficiency in men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Effects of graded doses of testosterone on erythropoiesis in healthy young and older men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Endocrine aspects of obstructive sleep apnea

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Patient information page from The Hormone Foundation. Patient guide to testosterone therapy in adult men with androgen deficiency syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Effect of testosterone treatment on constitutional and sexual symptoms in men with type 2 diabetes in a randomized, placebo-controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Sex hormone-binding globulin gene expression and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Further Studies on Leydig Cell Function in Old Age

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Age variation of the 24-hour mean plasma concentrations of androgens, estrogens, and gonadotropins in normal adult men

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Reproductive functions in young fathers and grandfathers

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Transient hypogonadotropic hypogonadism caused by critical illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Decreased pituitary-gonadal secretion in men with obstructive sleep apnea

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Premature decline of serum total testosterone in HIV-infected men in the HAART-era

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Effect of 2 years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Low Testosterone Associated With Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men With Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Effect of testosterone treatment on glucose metabolism in men with type 2 diabetes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Effect of testosterone propionate on erythropoiesis after experimental orchiectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Hemorheological parameters as independent predictors of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Hematocrit and risk of venous thromboembolism in a general population. The Tromso study

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander?

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Physiological normal levels of androgen inhibit proliferation of prostate cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Endocrine alterations in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Hypogonadism in human immunodeficiency virus-positive men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Hypogonadism associated with long-term opioid therapy: A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

Stimulation of Erythropoiesis by Androgenic Hormones

1 reference

https://api.crossref.org/works/10.1016%2FJ.MAYOCP.2016.04.022

7 January 2021

10.1016/J.MAYOCP.2016.04.022

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27343020%20AND%20SRC:MED&resulttype=core&format=json